Morningstar Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Morningstar Investment Management's PFE Position: Q2 2026 in Review
Morningstar Investment Management held its Pfizer (PFE) position steady in Q2 2026 at 274,915 shares worth $7.72M. The position accounts for 0.48% of the portfolio, ranked #40.
Morningstar Investment Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.32M in Q3 2025. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Morningstar Investment Management held 274,915 shares of Pfizer worth $7.72M as of Q2 2026.
- Morningstar Investment Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.48% of Morningstar Investment Management's portfolio in Q2 2026, its #40 holding.
- Morningstar Investment Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- Morningstar Investment Management's Pfizer position peaked at $8.32M in Q3 2025.
- 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.